[Hair Loss Peptide](/)

[What the hair studies can actually tell us](/ghk-cu)

[How to take a hair concern to a clinician](/safety-and-care)

[About](/about)

[Home](/) / GHK-Cu evidence

# GHK-Cu still leaves the hair question open.

Copper peptide has an interesting hair story. It also has a missing piece: the small human hair trial didn’t test GHK-Cu alone. We’ll keep that distinction in view, because it changes what the study can tell you.

## The copper in the name

![A small folded piece of copper beside a few clipped hair fibres on paper.](/scalp-paper-a3e549d8fa39/copper-beside-hair-fibres.webp)

GHK-Cu has copper attached. The human combination study used GHK without it.

Three amino acids make up GHK; they’re the building blocks of protein. [GHK-Cu is that chain with copper attached](https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/). The extra letters matter when we’re describing an experiment.

The human hair trial used GHK without copper. Calling its result a finding for GHK-Cu would swap one ingredient for another. Similar names don’t make them the same test.

## The human study tested a mixture

We can give the study credit without giving one ingredient all the credit. Taking the second ingredient out of the explanation doesn’t take it out of the experiment.

### What went on the scalp

[Lee and colleagues studied men with male-pattern hair loss](https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/). Their lotion combined GHK without copper and 5-aminolevulinic acid, another ingredient. They compared it with a dummy lotion over six months.

### What changed

Hair counts rose more with the mixture. Hair thickness and length didn’t differ significantly between groups. That’s a finding about the tested lotion. It doesn’t tell us how much GHK contributed or whether GHK-Cu alone would help.

## Mice and lab samples tell different stories

Another study tested [a GHK-Cu delivery system in mice](https://pubmed.ncbi.nlm.nih.gov/38026438/), looking at how it reached the skin and affected hair-growth signals. It helps explain the scientific interest. It doesn’t establish a treatment for people.

A separate copper-peptide study used AHK-Cu in [human hair tissue and cells outside the body](https://pubmed.ncbi.nlm.nih.gov/17703734/). AHK-Cu is a different peptide. ‘Human’ describes where the tissue came from; it doesn’t mean people received treatment.

## No reported side effects isn’t the whole safety answer

The human combination trial reported no side effects. A small study can miss uncommon harms, though, and it can’t settle long-term safety. A lotion result also can’t tell us whether an injection is safe.

[FDA’s injectable GHK-Cu entry](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks) raises concerns about immune reactions linked to clumping and impurities, with little human safety information. On its page current as of April 22, 2026, the entry is ‘nominated but withdrawn’: the request to consider it was taken back. That isn’t clearance or approval. Personal hair questions belong with a licensed clinician.

Our [safety and care page](/safety-and-care) explains the practical differences. The papers and FDA records are on [references](/references).

Hair Loss Peptide is a guide for hair questions, where we explain the reading without providing clinical care, pharmacy services or sales.

[References](/references) · [Other peptides](/other-peptides) · [The hair question](/hair-loss) · [Contact](/contact)

© 2026 Hair Loss Peptide
